Genetic Immunization with CDR3-Based Fusion Vaccine Confers Protection and Long-Term Tumor-Free Survival in a Mouse Model of Lymphoma
Figure 3
In vivo antitumor effects generated by immunization with pTTCDR3 vaccine. (a) Tumor resistance. (*) denotes a statistically significant value () by analysis when comparing the pTTCDR3 group ( = 7) to all other groups ( = 6). (b) Representative long-term tumor-free survival. Survival analyses were performed using the Kaplan-Meier method and the log-rank test ().
